These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8900495)

  • 1. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.
    Pairet M; Engelhardt G
    Fundam Clin Pharmacol; 1996; 10(1):1-17. PubMed ID: 8900495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
    Kam PC; See AU
    Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction: mechanism of action of NSAIDs.
    Vane JR
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():1-3. PubMed ID: 8630629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
    Ohara M; Sawa T
    Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition and thrombogenicity.
    Catella-Lawson F; Crofford LJ
    Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and clinical action of COX-2 selective NSAIDs.
    Bovill JG
    Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
    [No Abstract]   [Full Text] [Related]  

  • 9. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New NSAIDs and gastroduodenal damage.
    Folco GC
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
    Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of COX-2-selective inhibitors.
    Brater DC; Harris C; Redfern JS; Gertz BJ
    Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 inhibitors: a review.
    Houston AM; Teach SJ
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-inflammatory drugs and their mechanism of action.
    Vane JR; Botting RM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S78-87. PubMed ID: 9831328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.
    Brooks P; Emery P; Evans JF; Fenner H; Hawkey CJ; Patrono C; Smolen J; Breedveld F; Day R; Dougados M; Ehrich EW; Gijon-Baños J; Kvien TK; Van Rijswijk MH; Warner T; Zeidler H
    Rheumatology (Oxford); 1999 Aug; 38(8):779-88. PubMed ID: 10501435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
    Flower RJ
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
    Buttar NS; Wang KK
    Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of selective cyclooxygenase-2 inhibition.
    Emery P
    Scand J Rheumatol Suppl; 1996; 102():23-8. PubMed ID: 8628978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.